Incompatibilities: 75 IU: MENOPUR should not be administered in the same injection with other products.
600 IU and 1200 IU: MENOPUR should not be administered in the same injection with other products, except Ferring's urofollitrophin (FSH) BRAVELLE. Studies have shown that co-administration of BRAVELLE and MENOPUR does not significantly alter the expected bioactivity.
Precautions for disposal: 75 IU: The powder should only be reconstituted with the solvent provided in the package. The reconstituted solution should not be administered if it contains particles or is not clear. Any unused product or waste material should be disposed in accordance with local requirements.
Other handling information: 75 IU: Attach a reconstitution needle to the syringe. Withdraw the entire content from the ampoule with solvent and inject the total contents into the vial containing the powder. When the solvent needle pierces the vial there is a slight vacuum inside the vial which may lead to the powder completely dissolving with only a few drops of solvent. This may give the false impression that there was no powder in the vial, be sure to add the entire solvent and proceed to the next step of administration. Shaking should be avoided.
If needed, the solution can be drawn up into the syringe again to transfer it to the next vial with powder until the prescribed dose has been reached. Up to three powder vials can be dissolved with one ampoule of solvent.
When the prescribed dose has been reached, draw up the mixed solution from the vial into the syringe, change to a hypodermic needle and administer immediately.
Instructions for Use and Handling: 600 IU and 1200 IU: The powder should only be reconstituted with the solvent provided in the package.
Attach a reconstitution needle to the syringe. Withdraw the entire content from the ampoule with solvent and inject the total contents into the vial containing the powder. The powder should dissolve quickly to a clear solution. If not, roll the vial gently between the hands until the solution is clear. Shaking should be avoided.
The single use administration syringes with pre-fixed needle are graduated in FSH/LH units from 37.5-600 IU.
Draw up the reconstituted solution from the vial into the administration syringe for injection according to the prescribed dose and administer the dose immediately. Each ml of reconstituted solution contains 600 IU FSH and LH.
Each reconstituted MENOPUR multidose 600 IU or 1200 IU vial should be for individual patient use only.
The reconstituted solution should not be administered if it contains particles or is not clear.
Any unused product or waste material should be disposed in accordance with local requirements.